DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sobrero AF et al.
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.
J Clin Oncol 2008;
26 (14) 2311-2319
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.